4D Molecular Therapeutics, Inc. FDMT
$8.77
▼ -0.06% 24H
About
4D Molecular Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing genetic medicines for ophthalmology and pulmonology diseases. It utilizes its proprietary Therapeutic Vector Evolution platform to create customized adeno-associated virus vectors that enable targeted, durable delivery of th…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees196
TickerFDMT
Statistics
Market Cap$458.2M
Revenue (TTM)$85.2M
Net Income-$140.1M
Net Margin-164.4%
EPS$-2.42
P/E-3.65
P/S5.23
P/B1.02
EV/EBITDA-0.53
ROE-34.9%
Dividend Yield—
Price$8.77
Data: Twelve Data · Revenue = mcap / P/S